RSV
Make RSV jab accessible: Sim
The new RSV vaccine is welcome, but steps need to be taken to ensure it reaches those who need it, says a leading pharmacist Following the approval of a new …
First RSV jab approved
The Therapeutic Goods Administration has approved a vaccine against respiratory syncytial virus, for Australians aged 60 and over AREXVY (respiratory syncytial virus vaccine, adjuvanted) is the first RSV vaccine to …
Clinical tips: Respiratory syncytial virus (RSV)
There has been a resurgence of RSV following the end of COVID pandemic measures, writes Karalyn Huxhagen Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infection …